This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Drugmakers are urging the Trump administration and EU officials to exclude medic...
Sarepta Therapeutics said that a young man died after receiving Elevidys, its ge...
Opinion/decision on a Paediatric investigation plan (PIP): Rapiscan, Regadenoson...
Clinical Trial Information System (CTIS) structured data form - Initial applicat...
Agenda of the CAT meeting 19-21 March 2025
Having recently trimmed back its pipeline to a sole cancer candidate, Pyxis Onco...
Product Management Service (PMS) webinar : Unlocking Integration – MAH & Softwar...
ICH M11 Technical Specification - Updated step 2b
Essential biotech news updates, brought to you by The Readout.
Sarepta Therapeutics said that a young man died after receiving Elevidys, its ge...
ICH M11 guideline, clinical study protocol template and technical specifications...
CVMP recommendations on limited market classification and eligibility for author...
Seizing opportunities in a changing medicines landscape: The European medicines ...
EMA and the Heads of Medicines Agencies (HMA) have published their joint EU medi...
Kiromic BioPharma has put 31 people on furlough. The cell therapy biotech has st...
Clinical trial tech company Clario has sealed its second acquisition in a week, ...
As other gene editing programs fold or get sold, Arbor Biotechnologies has raise...
At a time when CRISPR companies have struggled, the Feng Zhang spinoff Arbor Bio...